29.4.2006   

EN

Official Journal of the European Union

L 116/61


COMMISSION DECISION

of 16 March 2006

approving the Member States’ survey programmes for avian influenza in poultry and wild birds during 2006

(notified under document number C(2006) 780)

(2006/314/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 20 thereof,

Whereas:

(1)

Council Decision 90/424/EEC provides for a Community financial contribution for the undertaking of technical and scientific measures necessary for the development of Community veterinary legislation and for veterinary education or training.

(2)

Commission Decision 2006/101/EC on the implementation of survey programmes for avian influenza in poultry and wild birds to be carried out in the Member States in 2006 (2) provides for the implementation in the period from February to December 2006 of such surveys subject to those survey programmes being approved by the Commission. Those surveys are to investigate the presence of infections in poultry, which could lead to a review of current Community legislation and contribute to the knowledge of the possible threats for animals and humans from the wildlife.

(3)

The survey programmes submitted by Member States have been examined by the Commission in accordance with that Decision.

(4)

The Commission has found that the survey programmes submitted by the Member States comply with Decision 2006/101/EC. Those survey programmes should therefore be approved.

(5)

In the light of the importance of those survey programmes for the achievement of Community objectives in the field of animal and public health, it is appropriate to fix the Community financial contribution at 50 % of the costs to be incurred by the Member States concerned for the measures referred to in this Decision up to a maximum amount for each survey programme.

(6)

Expenditures in relation to the survey programmes approved by this Decision that have been incurred since 1 February 2006 should also be considered eligible for co-financing by the Community.

(7)

Furthermore, it is appropriate to lay down rules for reporting the results of the surveys and for the eligibility of the costs contained in the financial claim for a Community financial contribution for the costs incurred by Member States for the implementation of the survey programmes.

(8)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

The Member States’ programmes for avian influenza in poultry and wild birds listed in Annex I are approved for the period set out in that Annex (‘the programmes’).

Article 2

The Member States shall carry out surveys for avian influenza in poultry and wild birds in accordance with the programmes.

Article 3

The Community financial contribution to the costs for analysing samples shall be granted to each Member State at the rate of 50 % of the costs incurred and up to the maximum amount for co-financing set out in Annex I.

That Community financial contribution shall be granted provided that the Member State concerned complies with the following:

(a)

brings into force the laws, regulations or administrative provisions necessary for implementing its programme;

(b)

submits a final report to the Commission and to the Community Reference Laboratory for avian influenza as referred to in Article 51(1) of Council Directive 2005/94/EC (3) by 31 March 2007 at the latest, on the technical execution of the programme and the results attained, in accordance with the reporting models set out in Annexes II to V to this Decision;

(c)

submits appropriate evidence to the Commission as to the costs incurred for analysing samples during the period for which the programme is approved;

(d)

implements the programme efficiently, in particular the competent authority must ensure that appropriate sampling is performed.

Article 4

The maximum amounts of the costs to be reimbursed to the Member States for the tests covered by the programmes shall not exceed the following:

(a)

:

ELISA test

:

EUR 1 per test;

(b)

:

agar gel immune diffusion test

:

EUR 1,2 per test;

(c)

:

HI test for H5/H7

:

EUR 12 per test;

(d)

:

virus isolation test

:

EUR 30 per test;

(e)

:

PCR test

:

EUR 15 per test.

Article 5

This Decision is addressed to the Member States.

Done at Brussels, 16 March 2006.

For the Commission

Markos KYPRIANOU

Member of the Commission


(1)  OJ L 224, 18.8.1990, p. 19. Decision as last amended by Council Decision 2006/53/EC of 23 January 2006 (OJ L 29, 2.2.2006, p. 37).

(2)  OJ L 46, 16.2.2006, p. 40.

(3)  OJ L 10, 14.1.2006, p. 16.


ANNEX I

Member States' programmes for avian influenza surveys in poultry and wild birds

Code

Member State

Period

Maximum amount for co-financing of samples

(EUR)

BE

Belgium

1 February 2006 to 31 December 2006

38 400,00

CZ

Czech Republic

1 February 2006 to 31 December 2006

33 400,00

DK

Denmark

1 February 2006 to 31 December 2006

168 500,00

DE

Germany

1 February 2006 to 31 December 2006

268 000,00

EE

Estonia

1 February 2006 to 31 December 2006

1 450,00

EL

Greece

1 February 2006 to 31 December 2006

39 300,00

ES

Spain

1 February 2006 to 31 December 2006

88 100,00

FR

France

1 February 2006 to 31 December 2006

204 800,00

IE

Ireland

1 February 2006 to 31 December 2006

42 500,00

IT

Italy

1 February 2006 to 31 December 2006

427 300,00

CY

Cyprus

1 February 2006 to 31 December 2006

20 700,00

LV

Latvia

1 February 2006 to 31 December 2006

11 600,00

LT

Lithuania

1 February 2006 to 31 December 2006

15 400,00

LU

Luxembourg

1 February 2006 to 31 December 2006

4 400,00

HU

Hungary

1 February 2006 to 31 December 2006

109 500,00

MT

Malta

1 February 2006 to 31 December 2006

3 700,00

NL

The Netherlands

1 February 2006 to 31 December 2006

54 500,00

AT

Austria

1 February 2006 to 31 December 2006

28 550,00

PL

Poland

1 February 2006 to 31 December 2006

94 500,00

PT

Portugal

1 February 2006 to 31 December 2006

71 600,00

SI

Slovenia

1 February 2006 to 31 December 2006

23 500,00

SK

Slovakia

1 February 2006 to 31 December 2006

11 600,00

FI

Finland

1 February 2006 to 31 December 2006

32 600,00

SE

Sweden

1 February 2006 to 31 December 2006

77 200,00

UK

United Kingdom

1 February 2006 to 31 December 2006

93 700,00

Total

1 964 800,00


ANNEX II

FINAL REPORT ON SAMPLED POULTRY HOLDINGS (1)

(except ducks and geese)

Serological investigation according to point B to the Annex to Commission Decision 2006/101/EC on holdings of broilers (only when at risk)/fattening turkeys/chicken breeders/turkey breeders/laying hens/free range laying hens/ratites/farmed feathered game (pheasants, partridges, quails and others)/‘non-commercial holdings’ (as defined in Article 2 of Council Directive 2005/94/EC/others [delete as appropriate]

PLEASE USE ONE FORM PER POULTRY CATEGORY!

 

Member State:

 

Date:

 

Reporting period from:

 

to:


Region (2)

Total number of holdings (3)

Total number of holdings sampled

Total number of positive holdings

Number of positive holdings for subtype H 5

Number of positive holdings for subtype H 7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 


(1)  Holdings equals herds, flocks or establishments as appropriate.

(2)  Region as defined in the approved programme of the Member State.

(3)  Total number of holdings of one category of poultry in a region.


ANNEX III

FINAL REPORT ON DATA ON DUCK AND GEESE HOLDINGS (1)

According to point C to the Annex to Commission Decision 2006/101/EC Serological investigation (2)

 

Member State:

 

Date:

 

Reporting period from:

 

to:


Region (2)

Total number of duck and geese holdings

Total number of duck and geese holdings sampled

Total number of serological positive holdings

Number of serological positive holdings for subtype H5

Number of serological positive holdings for subtype H7

Total number of virological positive holdings

Number of virological positive holdings for subtype H5

Number of virological positive holdings for subtype H7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 


(1)  Holdings equals herds, flocks or establishments as appropriate.

(2)  Region as defined in the approved programme of the Member State.


ANNEX IV

FINAL REPORT ON DATA ON WILD BIRDS

Investigation according to point D to the Annex to Commission Decision 2006/101/EC

 

Member State:

 

Date:

 

Reporting period from:

 

to:


Region (1)

Species of wild birds sampled

Total number of samples taken for examination

Total number of positive samples

Number of positive samples for subtype H5

Number of positive samples for subtype H7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 


(1)  Region as defined in the approved programme of the Member State or indication of location of bird watching station(s).


ANNEX V

FINAL FINANCIAL REPORT AND PAYMENT APPLICATION

One table per survey in poultry/wild birds (1)

 

Member State:

 

Date:

 

Reporting period from:

 

to:


Measures eligible for co-financing (2)

Methods of laboratory analysis

Number tests performed per method

Costs

Serological pre-screening (3)

 

 

Haemagglutination-inhibition-test (HI) for H5/H7

 

 

Virus isolation test

 

 

PCR test

 

 

Other measures to be covered

Specify activities

 

Sampling

 

 

Others

 

 

Total

 

 

Herewith I certify that the data given above are correct and that no other Community contribution was asked for these measures.


(1)  Strike through as appropriate.

(2)  Data to be given in national currency, VAT excluded ... (Place, Date)

(3)  Please indicate test used. ... (Signature)